Despite of this, the discordance between in vitro and in vivo E2 effects on cell proliferation essentially indicates that circulating estrogens promote the outgrowth of ERα-negative cancers by influencing host cell types distinct from the epithelial ovarian cancer cells. The gene discussed is ESR1; the disease is ovarian carcinoma.